Changes in effectiveness and safety in patients with Lennox-Gastaut syndrome transitioning from the fenfluramine randomized controlled trial to open-label extension study.
- DOI
- 10.1002/epi4.70320
- Published
- 2026-08-03
- Container
- Epilepsia Open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/epi4.70320,
title = {Changes in effectiveness and safety in patients with Lennox-Gastaut syndrome transitioning from the fenfluramine randomized controlled trial to open-label extension study.},
author = {Nabbout R and Devinsky O and Lagae L and Scheffer IE and Guerrini R and Sullivan J and Gil-Nagel A and Zuberi SM and Riney K and Healy P and Abraham J and Roper RZ and Langlois M and Lothe A and Knupp KG.},
year = {2026},
journal = {Epilepsia Open},
doi = {10.1002/epi4.70320},
url = {https://doi.org/10.1002/epi4.70320}
}RIS
TY - JOUR TI - Changes in effectiveness and safety in patients with Lennox-Gastaut syndrome transitioning from the fenfluramine randomized controlled trial to open-label extension study. AU - Nabbout R AU - Devinsky O AU - Lagae L AU - Scheffer IE AU - Guerrini R AU - Sullivan J AU - Gil-Nagel A AU - Zuberi SM AU - Riney K AU - Healy P AU - Abraham J AU - Roper RZ AU - Langlois M AU - Lothe A AU - Knupp KG. PY - 2026 JO - Epilepsia Open DO - 10.1002/epi4.70320 UR - https://doi.org/10.1002/epi4.70320 ER -
APA
R, N., O, D., L, L., IE, S., R, G., J, S., A, G., SM, Z., K, R., P, H., J, A., RZ, R., M, L., A, L., & KG., K. (2026). Changes in effectiveness and safety in patients with Lennox-Gastaut syndrome transitioning from the fenfluramine randomized controlled trial to open-label extension study.. Epilepsia Open. https://doi.org/10.1002/epi4.70320
Source records
- europe-pmc · retrieved 2026-09-25T02:31:26.731Z